GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TiumBio Co Ltd (XKRX:321550) » Definitions » Retained Earnings

TiumBio Co (XKRX:321550) Retained Earnings : ₩-121,204 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is TiumBio Co Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. TiumBio Co's retained earnings for the quarter that ended in Dec. 2023 was ₩-121,204 Mil.

TiumBio Co's quarterly retained earnings increased from Jun. 2023 (₩-125,378 Mil) to Sep. 2023 (₩-125,158 Mil) and increased from Sep. 2023 (₩-125,158 Mil) to Dec. 2023 (₩-121,204 Mil).

TiumBio Co's annual retained earnings declined from Dec. 2021 (₩-73,413 Mil) to Dec. 2022 (₩-103,293 Mil) and declined from Dec. 2022 (₩-103,293 Mil) to Dec. 2023 (₩-121,204 Mil).


TiumBio Co Retained Earnings Historical Data

The historical data trend for TiumBio Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TiumBio Co Retained Earnings Chart

TiumBio Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Retained Earnings
Get a 7-Day Free Trial -29,657.07 -41,775.90 -73,413.09 -103,293.39 -121,204.31

TiumBio Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -103,293.39 -111,224.04 -125,378.45 -125,158.22 -121,204.31

TiumBio Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


TiumBio Co  (XKRX:321550) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


TiumBio Co (XKRX:321550) Business Description

Traded in Other Exchanges
N/A
Address
49, Daewangpangyo-ro 644beon-gil, Bundang-gu, 4th floor, Gyeonggi, Seongnam, KOR, 13493
TiumBio Co Ltd is a Biopharmaceutical company. It is engaged in research and development of rare and intractable diseases. The company's products are in pipeline. It offers products such as Idiopathic pulmonary fibrosis therapies, immune chemotherapy, endometriosis therapies, hemophilia.

TiumBio Co (XKRX:321550) Headlines

No Headlines